QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Jaguar Supports Proof-Of-Concept Studies For Rare Disease Indications With Results Expected By End Of 2024 And 2025

 why-jaguar-health-jagx-stock-is-down-15

Jaguar Health shares are trading lower by 15.4% during Tuesday's session. The company reported worse-than-expected second-q...

 jaguar-health-q2-eps-404-misses-111-estimate-sales-272m-miss-394m-estimate

Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(4.04) per share which missed the analyst consensus estimate of $(1.1...

 why-jaguar-health-stock-is-crashing

Jaguar Health shares are falling Tuesday after the company announced its phase 3 OnTarget trial did not meet its primary endpoi...

 jaguar-health-announces-webcast-on-july-23-to-discuss-phase-3-ontarget-trial-results-for-crofelemer

Will Include Updates On Cancer Supportive Care Portfolio And Expansion Of Make Cancer Less Shitty Program With MCLS Ambassadors

 jaguar-health-to-present-phase-3-ontarget-trial-results-for-its-cancer-supportive-care-drug-crofelemer-on-or-before-july-23-2024

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including particip...

 jaguar-health-and-magdalena-biosciences-executes-out-license-deal-with-for-botanical-drug-candidate-for-schizophrenia

The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for s...

 whats-going-on-with-jaguar-health-stock

Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION